Information Journal Paper
APA:
CopyMAMOUNAS, E., BRYANT, J., LEMBERSKY, B., FEHRENBACHER, L., SEDLACEK, S., & FISHER, B.. (2005). PACLITAXEL AFTER DOXORUBICIN PLUS CYCLOPHOSPHAMIDE AS ADJUVANT CHEMOTHERAPY FOR NODE-POSITIVE BREAST CANCER: RESULTS FROM NSABP B-28. JOURNAL OF CLINICAL ONCOLOGY, 23(16), 3686-3696. SID. https://sid.ir/paper/585468/en
Vancouver:
CopyMAMOUNAS E., BRYANT J., LEMBERSKY B., FEHRENBACHER L., SEDLACEK S., FISHER B.. PACLITAXEL AFTER DOXORUBICIN PLUS CYCLOPHOSPHAMIDE AS ADJUVANT CHEMOTHERAPY FOR NODE-POSITIVE BREAST CANCER: RESULTS FROM NSABP B-28. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 2005;23(16):3686-3696. Available from: https://sid.ir/paper/585468/en
IEEE:
CopyE. MAMOUNAS, J. BRYANT, B. LEMBERSKY, L. FEHRENBACHER, S. SEDLACEK, and B. FISHER, “PACLITAXEL AFTER DOXORUBICIN PLUS CYCLOPHOSPHAMIDE AS ADJUVANT CHEMOTHERAPY FOR NODE-POSITIVE BREAST CANCER: RESULTS FROM NSABP B-28,” JOURNAL OF CLINICAL ONCOLOGY, vol. 23, no. 16, pp. 3686–3696, 2005, [Online]. Available: https://sid.ir/paper/585468/en